Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.12 (
PKG
)
2,515
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Tumor necrosis factor alpha
(
TNF
) increased progesterone production in preovulatory rat follicles in vitro. More than 1 h in the presence of
TNF
was needed to enhance progesterone secretion, which was only seen after 24 h of culture. Neither cAMP nor cGMP levels in media and follicles increased either at short (5-20 min) or long periods (6-24 h) after
TNF
stimulation. The protein kinase C (PKC) inhibitor, H-7, blocked
TNF
-stimulated progesterone in a dose-dependent manner (1-300 mM), with 50% inhibition corresponding to 5.2 microM H-7, it also blocked LH-stimulated progesterone production, but higher doses were needed (50% inhibition corresponding to 54.5 microM H-7). However, the cAMP- and
cGMP-dependent protein kinase
inhibitor, HA1004, did not block
TNF
stimulated progesterone. The PKC activator, phorbol 12-myristate 13-acetate (PMA), increased progesterone maximally at 32 nM and above. Low doses of PMA in combination with
TNF
increased progesterone levels above that stimulated by PMA alone; however with the highest does of PMA (320 nM),
TNF
was unable to increase follicular progesterone secretion. The time course of progesterone stimulation by PMA was similar to that of
TNF
. H-7 also blocked PMA and PMA +
TNF
stimulated progesterone accumulation, with a 50% inhibition corresponding to 4.2 and 4.1 microM H-7, respectively. These results indicate that PKC may be a mediator of
TNF
-stimulated progesterone secretion in preovulatory rat follicles.
...
PMID:Involvement of protein kinase C in regulating tumor necrosis factor alpha-stimulated progesterone production in rat preovulatory follicles in vitro. 184 53